Delivery Order SPE2DR25D7059-SPE2DR26F7MRT
- Not listed
- The Defense Logistics Agency awarded a $1,683.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5mL syringes. This contract, issued December 8, 2025, with completion targeted for December 30, 2025, represents a non-set-aside competitive award supporting federal medical supply procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.02 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This firm fixed price, non-set-aside delivery order was awarded on November 17, 2025, with an ultimate completion date of December 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,579.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of December 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that runs through December 2026 and serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,168.19 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and older, 0.5ml syringes), with an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The award represents a child order under the company's...
- The Defense Logistics Agency awarded a $1,177.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine (12 years and up) in 0.5ml syringes, with an ultimate completion date of October 3, 2025. This is a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,147.67 to AmerisourceBergen Drug Corp for Spikevax 2024-25 vaccine doses (0.5mL syringes for ages 12 and up) with a firm fixed price structure. The award, issued on June 4, 2025, with completion targeted for June 26, 2025, represents a non-set-aside, competitively awarded contract. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,202.77 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5ml syringes, with an ultimate completion date of December 5, 2025. This is a firm fixed price, non-set-aside contract performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5ml syringes with a ceiling value of $1,087.46. The contract employs firm fixed-price pricing, with an ultimate completion date of December 3, 2025, and was awarded on November 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SPIKEVAX 2024-25 vaccine (12 years and up), 0.5ml syringes, with a ceiling value of $5,887.40. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MRTDelivery Order
The Defense Logistics Agency awarded a $5,264 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine units (12 years and older), 0.5ml syringes, with an ultimate completion date of December 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role in federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains an extensive portfolio of federal contract awards covering vaccines, brand-name and generic medications, medical devices, and specialized healthcare commodities. The company's federal procurement history demonstrates consistent capability to meet competitive requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 12/5/25 |